Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2006 5
2007 8
2008 10
2009 5
2010 5
2011 4
2012 3
2013 4
2014 3
2016 1
2017 1
2018 4
2019 4
2020 7
2021 5
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
Wong F, Pappas SC, Curry MP, Reddy KR, Rubin RA, Porayko MK, Gonzalez SA, Mumtaz K, Lim N, Simonetto DA, Sharma P, Sanyal AJ, Mayo MJ, Frederick RT, Escalante S, Jamil K; CONFIRM Study Investigators. Wong F, et al. N Engl J Med. 2021 Mar 4;384(9):818-828. doi: 10.1056/NEJMoa2008290. N Engl J Med. 2021. PMID: 33657294 Clinical Trial.
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension.
Chalasani N, Abdelmalek MF, Garcia-Tsao G, Vuppalanchi R, Alkhouri N, Rinella M, Noureddin M, Pyko M, Shiffman M, Sanyal A, Allgood A, Shlevin H, Horton R, Zomer E, Irish W, Goodman Z, Harrison SA, Traber PG; Belapectin (GR-MD-02) Study Investigators. Chalasani N, et al. Gastroenterology. 2020 Apr;158(5):1334-1345.e5. doi: 10.1053/j.gastro.2019.11.296. Epub 2019 Dec 5. Gastroenterology. 2020. PMID: 31812510 Free article. Clinical Trial.
Hepatitis A.
Kemmer NM, Miskovsky EP. Kemmer NM, et al. Infect Dis Clin North Am. 2000 Sep;14(3):605-15. doi: 10.1016/s0891-5520(05)70123-9. Infect Dis Clin North Am. 2000. PMID: 10987112 Review.
Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis.
Frenette C, Kayali Z, Mena E, Mantry PS, Lucas KJ, Neff G, Rodriguez M, Thuluvath PJ, Weinberg E, Bhandari BR, Robinson J, Wedick N, Chan JL, Hagerty DT, Kowdley KV; IDN-6556-17 Study Investigators. Frenette C, et al. J Hepatol. 2021 Feb;74(2):274-282. doi: 10.1016/j.jhep.2020.09.029. Epub 2020 Oct 8. J Hepatol. 2021. PMID: 33038432 Clinical Trial.
Malleable Transplant Criteria: At What Cost?
Alsina A, Apple R, Kemmer N, Orlowski JP. Alsina A, et al. Among authors: kemmer n. Narrat Inq Bioeth. 2019;9(1):77-82. doi: 10.1353/nib.2019.0020. Narrat Inq Bioeth. 2019. PMID: 31031293
Addressing the Burden and Management Strategies for Disparities and Inequities Among Liver Transplant Professionals: The ILTS Experience.
Andacoglu O, Izzy M, Adelmann D, Aguilera V, Becchetti C, Berenguer M, Berlakovich GA, Ghosh S, Giorgakis E, Kemmer N, Lunsford KE, Montasser IF, Montenovo MI, Mrzljak A, Pai SL, Scalera I, Selzner N. Andacoglu O, et al. Among authors: kemmer n. Transpl Int. 2023 Jun 2;36:11240. doi: 10.3389/ti.2023.11240. eCollection 2023. Transpl Int. 2023. PMID: 37334014 Free PMC article. Review.
Ethnic variations in chronic liver diseases.
Kemmer N, Neff GW. Kemmer N, et al. Dig Dis Sci. 2008 May;53(5):1339-44. doi: 10.1007/s10620-007-9992-0. Epub 2007 Oct 13. Dig Dis Sci. 2008. PMID: 17934812 Review.
62 results